Led by University of Cincinnati and Cincinnati Children’s researchers, new trial results published in The Lancet Psychiatry found the drug metformin can help manage weight gain in youth taking ...

The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...

NDA submission expected in early Q1 2026 for expanded usage of IGALMI® in home setting based on positive data from the ...

Thousands of dollars in free healthcare services available this month as researchers tackle rising pregnancy complications ...

The ketogenic diet significantly improves symptoms in epilepsy, schizophrenia, as well as in alcohol use disorder, opioid use ...

Ms. Pai Panandiker is a seasoned commercial and operating leader with more than 20 years of global biopharmaceutical experience, including extensive leadership in neuroscience commercialization and in ...

The call will provide a corporate and financial update and go forward operational plans.

Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar ...

Mr. Rawls received an option to purchase 90,000 shares of LB Pharmaceuticals’ common stock. The option carries a ten-year term and an exercise price per share equal to $14.61, which was the closing ...

Each year, about 100,000 Americans experience psychosis, a serious condition that disrupts thoughts and perceptions so ...